Shattuck Labs Announces 2024 Annual Meeting of Stockholders on June 7

TL;DR

<b>Shattuck Labs will hold its 2024 virtual Annual Meeting of Stockholders on June 7, 2024, to elect directors and ratify the auditor.</b>

AI Summary

Shattuck Labs, Inc. (STTK) filed a Proxy Statement (DEF 14A) with the SEC on April 23, 2024. Shattuck Labs, Inc. will hold its 2024 Annual Meeting of Stockholders on June 7, 2024, at 11:30 a.m. ET. The meeting will be conducted exclusively online via live audio webcast. Stockholders will vote on electing three Class I director nominees. The selection of KPMG LLP as the independent registered public accounting firm for 2024 will be ratified. The record date for stockholders entitled to vote is April 11, 2024.

Why It Matters

For investors and stakeholders tracking Shattuck Labs, Inc., this filing contains several important signals. This meeting is a routine corporate governance event where shareholders exercise their voting rights on key company leadership and financial oversight matters. The virtual format aims to increase accessibility for stockholders to participate in the annual meeting.

Risk Assessment

Risk Level: low — Shattuck Labs, Inc. shows low risk based on this filing. The filing is a routine proxy statement for an annual meeting, with no immediate financial or operational changes indicated.

Analyst Insight

Review the director nominees and auditor ratification proposals to make an informed voting decision.

Key Numbers

• 3 — Class I director nominees (To be elected at the Annual Meeting)
• 2024 — Fiscal Year End (For which KPMG LLP is the auditor)
• 2027 — Annual Meeting of Stockholders (Until which Class I directors will serve)

Key Players & Entities

• Shattuck Labs, Inc. (company) — Registrant
• June 7, 2024 (date) — Date of Annual Meeting
• KPMG LLP (company) — Independent registered public accounting firm
• April 11, 2024 (date) — Record date

FAQ

Industry Context

Shattuck Labs operates in the pharmaceutical preparations industry, focusing on drug development.

Regulatory Implications

The filing is a Schedule 14A (DEF 14A), a proxy statement required by the SEC for public companies holding annual meetings.

What Investors Should Do

1. Register in advance for the virtual Annual Meeting.
2. Review the proxy statement for details on director nominees.
3. Consider the ratification of KPMG LLP as the independent auditor.

Key Dates

• 2024-06-07: 2024 Annual Meeting of Stockholders — Key date for voting on directors and auditor
• 2024-04-11: Record Date — Determines eligibility to vote at the Annual Meeting

Year-Over-Year Comparison

This is the initial filing for the 2024 Annual Meeting of Stockholders.

Filing Documents

• d658354ddef14a.htm (DEF 14A) — 306KB
• g658354g02a04.jpg (GRAPHIC) — 57KB
• g658354g37g37.jpg (GRAPHIC) — 355KB
• g658354g38g38.jpg (GRAPHIC) — 165KB
• 0001193125-24-107111.txt (&nbsp;) — 1102KB

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 21 CERTAIN INFORMATION ABOUT OUR COMMON STOCK 26 CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS 30 OTHER MATTERS 32 LEGAL MATTERS Important Notice Regarding the Availability of Proxy Materials for the 2024 Annual Meeting of Stockholders to Be Held on June 7, 2024 . The Proxy Statement and Annual Report for the year ended December 31, 2023 are available at www.proxydocs.com/STTK .

Forward-Looking Statements. The Proxy Statement may contain forward-looking statements within the meaning of the

Forward-Looking Statements. The Proxy Statement may contain forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, which statements are subject to substantial risks and uncertainties and are based on estimates and assumptions. All statements other than statements of historical fact included in the Proxy Statement, including statements about the Companys Board of Directors, corporate governance practices, executive compensation program and equity compensation utilization, are forward-looking statements. In some cases, you can identify forward-looking statements by terms such as may, might, will, objective, intend, should, could, can, would, expect, believe, design, estimate, predict, potential, plan or the negative of these terms, and similar expressions intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that could cause our actual results to differ materially from the forward-looking statements expressed or implied in the Proxy Statement. Such risks, uncertainties and other factors include those risks described in Risk Factors and Managements Discussion and Analysis of Financial Condition and Results of Operations in the Companys most recent Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (SEC) and other subsequent documents we file with the SEC. The Company expressly disclaims any obligation to update or alter any statements whether as a result of new information, future events or otherwise, except as required by law. Website References. Website references throughout this document are inactive textual references and provided for convenience only, and the content on the referenced websites is not incorporated herein by reference and does not constitute a part of the Proxy Statement. Use of Trademarks. Shattuck Labs is the trademark of Shattuck Labs, Inc. Other names and bra

View Full Filing

View this DEF 14A filing on SEC EDGAR